News
Read this guide to running in a weighted vest, which includes the potential benefits, precautions, and what you should know ...
GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the disease, including Trelegy (fluticasone furoate, umeclidinium, and ...
GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab) has ...
Kentucky has its first measles outbreak of 2025, as the U.S. case count sits just short of a 30-year high. There have been ...
BUIGX - Vest US Large Cap 10% Buffer StratsInstl - Review the BUIGX stock price, growth, performance, sustainability and more to help you make the best investments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results